Clinical Accelerator Leadership The CRI Anna-Maria Kellen Clinical Accelerator leadership is led by the field’s top scientific and clinical talent and a highly experienced senior management team. Clinical Accelerator Clinical and Scientific Advisory Committee Chair Jedd D. Wolchok, MD, PhD Weill Cornell Medicine Clinical Accelerator Clinical and Scientific Advisory Committee Neil H. Segal, MD, PhD Memorial Sloan Kettering Cancer Center Michel Sadelain, MD, PhD Memorial Sloan Kettering Cancer Center Lawrence Fong, MD University of California, San Francisco George Coukos, MD, PhD Ludwig Cancer Research and University Hospitals of Canton Vaud (CHUV) Julie R. Brahmer, MD Johns Hopkins Kunle Odunsi, MD, PhD The University of Chicago E. John Wherry, PhD University of Pennsylvania School of Medicine Nina Bhardwaj, MD, PhD Icahn School of Medicine at Mount Sinai F. Stephen Hodi, MD Dana-Farber Cancer Institute Dirk Jaeger, MD National Center for Tumor Diseases Heidelberg Elizabeth M. Jaffee, MD Johns Hopkins University School of Medicine Carl H. June, MD University of Pennsylvania School of Medicine Antoni Ribas, MD, PhD University of California, Los Angeles Comprehensive Cancer Center Padmanee Sharma, MD, PhD The University of Texas MD Anderson Cancer Center Craig L. Slingluff Jr., MD University of Virginia Health System Pramod K. Srivastava, MD, PhD University of Connecticut School of Medicine Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania Cassian Yee, MD The University of Texas MD Anderson Cancer Center CRI Clinical Accelerator and Venture Fund Management Team Samik Upadhaya, PhD Assistant Director, Scientific Affairs Ana Rosa Sáez Ibáñez, PhD Research Analyst, Clinical Accelerator and Venture Fund Jay Campbell Managing Director, CRI Clinical Accelerator and Venture Fund Jill O’Donnell-Tormey, PhD Chief Executive Officer and Director of Scientific Affairs
